Multiple Sclerosis

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benedict, R H.
Right arrow Articles by Jacobs, L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benedict, R H.
Right arrow Articles by Jacobs, L
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Multiple Sclerosis, Vol. 9, No. 1, 95-101 (2003)
DOI: 10.1191/1352458503ms861oa

Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire

R HB Benedict

Department of Neurology, State University of New York (SUNY) at Buffalo School of Medicine, Buffalo, New York, USA, Jacobs Neurological Institute, Buffalo, New York, USA, benedict{at}buffalo.edu

F Munschauer

Department of Neurology, State University of New York (SUNY) at Buffalo School of Medicine, Buffalo, New York, USA, Jacobs Neurological Institute, Buffalo, New York, USA

R Linn

Uniform Data Systems, Buffalo, New York, USA

C Miller

Department of Neurology, State University of New York (SUNY) at Buffalo School of Medicine, Buffalo, New York, USA, Jacobs Neurological Institute, Buffalo, New York, USA

E Murphy

Department of Neurology, State University of New York (SUNY) at Buffalo School of Medicine, Buffalo, New York, USA, Jacobs Neurological Institute, Buffalo, New York, USA

F Foley

Bernard Gimbel Comprehensive Multiple Sclerosis Center, Holy Name Hospital, Teaneck, New Jersey, USA

L Jacobs

Department of Neurology, State University of New York (SUNY) at Buffalo School of Medicine, Buffalo, New York, USA, Jacobs Neurological Institute, Buffalo, New York, USA

Since there is a need for cost-effective screening techniques to identify neuropsychological impairment in multiple sclerosis (MS) patients, and because existing methods require cognitive testing with subsequent interpretation by a neuropsychologist, a brief self-report procedure was developed to screen for neuropsychological impairment in MS. In the first phase of the study, a pool of 80 items was generated based on a literature review and consultation with healthcare professionals. The set was reduced to 15 via Rasch analysis. Using these items, a brief (five minute) MS Neuropsychological Screening Q uestionnaire (MSNQ), including patient- and informant-report forms, was composed. In phase II, 50 MS patients and their caregivers completed the MSNQ. A comprehensive neuropsychological test battery was also administered. A nalyses covered the reliability of the MSNQ and correlations between both patient- and informant-report scores and objective neuropsychological testing. C ronbach’s a coefficients were 0.93 and 0.94 for the patient- and informant-report forms, respectively, and both forms of the test were strongly correlated with a more general cognitive complaints questionnaire. The patient MSNQ form correlated significantly with measures of depression but not with objective tests of cognitive function. In contrast, the informant form was correlated with patient cognitive performance but not depression. A cut-off score of 27 on the informant form of the MSNQ optimally separated patients based on a neuropsychological summary score encompassing measures of processing speed and memory. There were two false-negatives and one false-positive, giving the test a sensitivity of 0.83 and a specificity of 0.97. It is concluded, therefore, that this self-administered neuropsychological screening test is reliable and predicts neuropsychological impairment in MS patients with a reasonable degree of accuracy.

Key Words: co gnitive impairment • depression • multiple sclerosis • neuropsychological testing • screening


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
R. Benedict, J. Duquin, S Jurgensen, R. Rudick, J Feitcher, F. Munschauer, M. Panzara, and B Weinstock-Guttman
Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire
Multiple Sclerosis, August 1, 2008; 14(7): 940 - 946.
[Abstract] [PDF]


Home page
Mult SclerHome page
R.A. Marrie and M. Goldman
Validity of performance scales for disability assessment in multiple sclerosis
Multiple Sclerosis, November 1, 2007; 13(9): 1176 - 1182.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P. A Arnett
Caregiver burden in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, October 1, 2007; 78(10): 1041 - 1041.
[Full Text] [PDF]


Home page
NeurologyHome page
O. Khan
Can clinical outcomes be used to detect neuroprotection in multiple sclerosis?
Neurology, May 29, 2007; 68(22_suppl_3): S64 - S71.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
P. Scherer, I.K. Penner, A. Rohr, H. Boldt, I. Ringel, H. Wilke-Burger, E. Burger-Deinerth, K. Isakowitsch, M. Zimmermann, S. Zahrnt, et al.
The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study
Multiple Sclerosis, April 1, 2007; 13(3): 402 - 411.
[Abstract] [PDF]


Home page
Mult SclerHome page
B A Parmenter, B Weinstock-Guttman, N Garg, F Munschauer, and R H. Benedict
Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test
Multiple Sclerosis, January 1, 2007; 13(1): 52 - 57.
[Abstract] [PDF]


Home page
Mult SclerHome page
L Julian, N M Merluzzi, and D C Mohr
The relationship among depression, subjective cognitive impairment, and neuropsychological performance in multiple sclerosis
Multiple Sclerosis, January 1, 2007; 13(1): 81 - 86.
[Abstract] [PDF]


Home page
Mult SclerHome page
M S. Deloire, M C Bonnet, E Salort, Y Arimone, M Boudineau, K G Petry, and B Brochet
How to detect cognitive dysfunction at early stages of multiple sclerosis?
Multiple Sclerosis, August 1, 2006; 12(4): 445 - 452.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
F A H van der Linden, J J Kragt, M Klein, H M van der Ploeg, C H Polman, and B M J Uitdehaag
Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use
J. Neurol. Neurosurg. Psychiatry, December 1, 2005; 76(12): 1677 - 1681.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
R. A. Marrie, G. J Chelune, D. M Miller, and J. A Cohen
Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosis
Multiple Sclerosis, February 1, 2005; 11(1): 69 - 75.
[Abstract] [PDF]


Home page
Mult SclerHome page
R. H. Benedict, D. Cox, L. L Thompson, F. Foley, B. Weinstock-Guttman, and F. Munschauer
Reliable screening for neuropsychological impairment in multiple sclerosis
Multiple Sclerosis, December 1, 2004; 10(6): 675 - 678.
[Abstract] [PDF]


Home page
NeurologyHome page
L. B. Krupp, C. Christodoulou, P. Melville, W. F. Scherl, W. S. MacAllister, and L. E. Elkins
Donepezil improved memory in multiple sclerosis in a randomized clinical trial
Neurology, November 9, 2004; 63(9): 1579 - 1585.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
I. Fishman, R. H. B. Benedict, R. Bakshi, R. Priore, and B. Weinstock-Guttman
Construct Validity and Frequency of Euphoria Sclerotica in Multiple Sclerosis
J Neuropsychiatry Clin Neurosci, August 1, 2004; 16(3): 350 - 356.
[Abstract] [Full Text] [PDF]